title: Challenges in the design and conduct of phase III brain tumor therapy trials.
authors.affiliation: University of Toronto and Toronto-Sunnybrook Regional Cancer Centre, ON, Canada.
authors.forename: J R
authors.initials: JR
authors.lastname: Perry
authors.forename: L M
authors.initials: LM
authors.lastname: DeAngelis
authors.forename: S C
authors.initials: SC
authors.lastname: Schold
authors.forename: P C
authors.initials: PC
authors.lastname: Burger
authors.forename: H
authors.initials: H
authors.lastname: Brem
authors.forename: M T
authors.initials: MT
authors.lastname: Brown
authors.forename: W J
authors.initials: WJ
authors.lastname: Curran
authors.forename: C B
authors.initials: CB
authors.lastname: Scott
authors.forename: M D
authors.initials: MD
authors.lastname: Prados
authors.forename: R
authors.initials: R
authors.lastname: Kaplan
authors.forename: J G
authors.initials: JG
authors.lastname: Cairncross
mesh_terms: D001932:Brain Neoplasms / Q000503:physiopathology / Q000628:therapy*; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D006801:Humans; D011379:Prognosis; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016019:Survival Analysis